IFITM3 promotes the expression of the MHC-I transcriptional regulator NLRC5 and facilitates its nuclear trafficking, enriching our understanding of the MHC-I regulatory mechanisms in SCLC. Here, IFITM3 is linked to small cell lung carcinoma.